The Biological Impacts of Sitagliptin on the Pancreas of a Rat Model of Type 2 Diabetes Mellitus: Drug Interactions with Metformin

Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is a beneficial class of antidiabetic drugs. However, a major debate about the risk of developing pancreatitis is still existing. The aim of the work was to study the histological and immunohistochemical effects of sitagliptin on both endocrin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shawky, Lamiaa M., Morsi, Ahmed A., El Bana, Eman, Hanafy, Safaa Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167819/
https://www.ncbi.nlm.nih.gov/pubmed/31881657
http://dx.doi.org/10.3390/biology9010006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167819/
https://www.ncbi.nlm.nih.gov/pubmed/31881657
http://dx.doi.org/10.3390/biology9010006

Ejemplares similares